Loading…
History from 2026-05-15 to 2026-07-02. Every number below is a fact from TED/TenderNed notices — who this buyer awards to, what it buys, and what is open right now.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| LABORATORIOS FARMACEUTICOS ROVI, S.A. | 2 | €283k | 2026-07-02 |
| ABBOTT LABORATORIES, S.A. | 1 | €9.7M | 2026-05-15 |
| PFIZER, S.L.U | 1 | €2.0M | 2026-06-16 |
| JANSSEN CILAG S.A. | 1 | €2.0M | 2026-06-26 |
| MERCK SHARP DOHME DE ESPAÑA, S.A. | 1 | €1.4M | 2026-06-04 |
| ABBVIE SPAIN, S.L.U | 1 | €1.3M | 2026-06-10 |
| ROCHE FARMA, S.A | 1 | €1.2M | 2026-06-25 |
| SANOFI-AVENTIS, S.A. | 1 | €1.2M | 2026-06-03 |
| GLAXOSMITHKLINE, S.A. | 1 | €1.1M | 2026-05-27 |
| BRISTOL MYERS SQUIBB, S.A.U. | 1 | €477k | 2026-06-15 |
| Novartis Farmaceutica S.A. | 1 | €164k | 2026-05-28 |
| ORGANON SALUD S L | 1 | €144k | 2026-06-18 |
| Category | Notices | Open | Latest |
|---|---|---|---|
33 Medical equipment & pharmaceuticals | 13 | 0 | 2026-07-02 |
Recurring categories with no open notice are re-tender candidates — this buyer has bought them before and will again.
| won by ABBVIE SPAIN, S.L.U |
| €1,285,200 |
| 2026-05-28 | SUMINISTRO DEL MEDICAMENTO RANIBIZUMAB (DOE), DEFERASIROX (DOE) Y OCTREOTIDA (DOE) SUSPENSIÓN PARA TODAS LAS ORGANIZACIONES DE SERVICIOS DE OSAKIDETZA | won by Novartis Farmaceutica S.A. | €163,784 |
| 2026-05-27 | SUMINISTRO DE LOS MEDICAMENTOS PEGINTERFERÓN ALFA-2A (DOE) PARA TODAS LAS ORGANIZACIONES DE SERVICIOS DE OSAKIDETZA Y CENTROS SANITARIOS DE TITULARIDAD PRIVADA Y SIN ÁNIMO DE LUCRO, SANITARIOS DE TITULARIDAD PRIVADA Y SIN ÁNIMO DE LUCRO. | won by LABORATORIOS FARMACEUTICOS ROVI, S.A. | €141,674 |
| 2026-05-27 | SUMINISTRO DE LOS MEDICAMENTOS BELANTAMAB MAFODOTINA (DOE) y DOSTARLIMAB (DOE) PARA TODAS LAS ORGANIZACIONES DE SERVICIOS DE OSAKIDETZA Y CENTROS SANITARIOS VINCULADOS. | won by GLAXOSMITHKLINE, S.A. | €1,092,658 |
| 2026-05-15 | Suministro del sistema de monitorización de glucosa mediante sensores tipo flash para las Organizaciones de Servicios de Osakidetza. | won by ABBOTT LABORATORIES, S.A. | €9,737,036 |